Ameriprise’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,711
| Closed | -$607K | – | 3998 |
|
|
2023
Q4 | $607K | Buy |
+25,711
| New | +$607K | ﹤0.01% | 3372 |
|
|
2023
Q1 | – | Sell |
-11,561
| Closed | -$73K | – | 4049 |
|
|
2022
Q4 | $73K | Sell |
11,561
-6,950
| -38% | -$43.9K | ﹤0.01% | 3836 |
|
|
2022
Q3 | $65K | Sell |
18,511
-3,750
| -17% | -$13.2K | ﹤0.01% | 3866 |
|
|
2022
Q2 | $66K | Sell |
22,261
-1,400
| -6% | -$4.15K | ﹤0.01% | 3812 |
|
|
2022
Q1 | $74K | Buy |
23,661
+150
| +0.6% | +$469 | ﹤0.01% | 3863 |
|
|
2021
Q4 | $79K | Sell |
23,511
-9,134
| -28% | -$30.7K | ﹤0.01% | 3884 |
|
|
2021
Q3 | $120K | Sell |
32,645
-1,705
| -5% | -$6.27K | ﹤0.01% | 3764 |
|
|
2021
Q2 | $149K | Sell |
34,350
-1,275
| -4% | -$5.53K | ﹤0.01% | 3783 |
|
|
2021
Q1 | $161K | Sell |
35,625
-8,176
| -19% | -$37K | ﹤0.01% | 3725 |
|
|
2020
Q4 | $243K | Buy |
43,801
+12,105
| +38% | +$67.2K | ﹤0.01% | 3578 |
|
|
2020
Q3 | $229K | Buy |
31,696
+14,675
| +86% | +$106K | ﹤0.01% | 3498 |
|
|
2020
Q2 | $60K | Buy |
+17,021
| New | +$60K | ﹤0.01% | 3610 |
|
|
2019
Q4 | – | Sell |
-17,018
| Closed | -$87K | – | 3768 |
|
|
2019
Q3 | $87K | Buy |
17,018
+150
| +0.9% | +$767 | ﹤0.01% | 3633 |
|
|
2019
Q2 | $121K | Sell |
16,868
-911
| -5% | -$6.54K | ﹤0.01% | 3628 |
|
|
2019
Q1 | $236K | Buy |
17,779
+560
| +3% | +$7.43K | ﹤0.01% | 3491 |
|
|
2018
Q4 | $136K | Buy |
17,219
+1,740
| +11% | +$13.7K | ﹤0.01% | 3490 |
|
|
2018
Q3 | $171K | Buy |
15,479
+1,060
| +7% | +$11.7K | ﹤0.01% | 3562 |
|
|
2018
Q2 | $194K | Sell |
14,419
-74,166
| -84% | -$998K | ﹤0.01% | 3487 |
|
|
2018
Q1 | $1.15M | Sell |
88,585
-78,959
| -47% | -$1.03M | ﹤0.01% | 2913 |
|
|
2017
Q4 | $1.54M | Sell |
167,544
-22,956
| -12% | -$211K | ﹤0.01% | 2785 |
|
|
2017
Q3 | $1.54M | Buy |
+190,500
| New | +$1.54M | ﹤0.01% | 2747 |
|